Basic Information
ID: ALA5124938
Type: Functional
Description: Antiviral activity against wild type HBV infected in human HepG2 2.2.15 cells assessed as reduction in viral replication pre incubated for 3 days followed by replacement with fresh compounds for another 3 days prior to pronase treatment by RT-qPCR analysis
Format: BAO_0000218
Organism: Hepatitis B virus
Cell type: HepG2.2.15
Target: Hepatitis B virus(ALA613497)
Document: ALA5120909
Antiviral activity against wild type HBV infected in human HepG2 2.2.15 cells assessed as reduction in viral replication pre incubated for 3 days followed by replacement with fresh compounds for another 3 days prior to pronase treatment by RT-qPCR analysis: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA5124938
EC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 229.26 | -0.59 | -0.59 |
| 404.40 | -1.66 | -1.66 |
| 444.43 | -1.78 | -1.78 |
| 409.42 | -1.25 | -1.25 |
| 428.43 | -1.08 | -1.08 |
| 419.42 | -1.64 | -1.64 |
| 444.43 | -1.78 | -1.78 |
| 721.75 | 2.54 | 2.54 |
| 434.43 | -1.40 | -1.40 |
| 405.39 | -1.95 | -1.95 |
| 418.44 | -0.69 | -0.69 |
| 434.43 | -1.40 | -1.40 |
| 434.43 | -1.40 | -1.40 |
| 444.43 | -1.78 | -1.78 |
| 394.41 | -1.27 | -1.27 |
| 395.39 | -1.56 | -1.56 |